GNS Healthcare Presents Results of Metastatic Colorectal Cancer Collaboration with the Alliance for Clinical Trials in Oncology at ESMO 2018

by GNS Healthcare | Oct 22, 2018 | Featured Posts, Press Releases

Study identifies clinical and molecular drivers of survival at baseline to allow better risk stratification at initiation of treatment CAMBRIDGE, Mass.– [October 22, 2018] – GNS Healthcare (GNS), a leading precision medicine company, presented results in metastatic...

GNS Healthcare Co-Founder and Chief Commercial Officer Iya Khalil Named to INC Magazine’s List of Top Female Founders for 2018

by GNS Healthcare | Oct 5, 2018 | Featured Posts, Press Releases

CAMBRIDGE, Mass.– October 5, 2018 – Each October, INC Magazine chooses leading women pioneers, entrepreneurs and innovators to profile in its annual Women Entrepreneurs issue. In their 2018 issue, GNS Co-Founder and Chief Commercial Officer Iya Khalil, PhD was...

GNS Healthcare Names Healthcare Analytics Executive David Gascoigne as Chief Operating Officer

by GNS Healthcare | Oct 3, 2018 | Press Releases

CAMBRIDGE, Mass.– October 3, 2018 – GNS Healthcare (GNS), a leading precision medicine company, has tapped data analytics veteran David Gascoigne as its Chief Operating Officer. Gascoigne has two decades of experience scaling and leading data analytics businesses in...

Clinical and Machine Learning Expert, Dr. Ziad Obermeyer Joins GNS Healthcare’s Strategic Advisory Board

by GNS Healthcare | Sep 18, 2018 | Press Releases

CAMBRIDGE, Mass.– September 18, 2018 – GNS Healthcare (GNS), a leading precision medicine company, today announced the appointment of Ziad Obermeyer, MD, Associate Professor of Health Policy and Management at the UC Berkeley School of Public Health, to its strategic...

Cross-Industry Collaboration of GNS Healthcare, Amgen and Alliance for Clinical Trials in Oncology to Leverage AI to Advance Understanding of Treatment Response in Metastatic Colorectal Cancer

by GNS Healthcare | Sep 6, 2018 | Press Releases

Collaboration to apply causal artificial intelligence and clinical trial data to identify factors that drive treatment response in patients with metastatic colorectal cancer CAMBRIDGE, Mass.– September 6, 2018 – GNS Healthcare (GNS), a leading precision medicine...

GNS Healthcare Taps Technology Leader as CTO to Drive Productization of Causal AI Platform

by GNS Healthcare | Aug 22, 2018 | Press Releases

CAMBRIDGE, Mass.– August 22, 2018 – GNS Healthcare (GNS), a leading precision medicine company, announced the hiring of veteran software executive Scott McKay as Chief Technology Officer. McKay brings over 25 years of hands-on experience in software development,...